Which mechanism contributes to the decline in aerobic capacity during cancer?

Which mechanism contributes to the decline in aerobic capacity during cancer?

• A. Pulmonary impairment, cardiac impairment, hematologic effects, vascular toxicity, and skeletal muscle damage.
• B. Increased maximum oxygen uptake due to tumor metabolism.
• C. Enhanced endurance from chemotherapy.
• D. Exclusive nervous system impairment.

Answer: (A)

Aerobic capacity is limited by how well the body delivers and uses oxygen during exercise, and cancer affects multiple systems that contribute to this. The lungs may not exchange gases efficiently (pulmonary impairment), the heart’s pumping ability can be reduced (cardiac impairment), blood oxygen-carrying capacity can drop due to anemia and other hematologic changes, the vasculature can be damaged or toxic (vascular toxicity), and skeletal muscles can waste away or have metabolic changes that reduce their ability to use oxygen. Taken together, these factors lower maximal oxygen uptake (VO2 max), which is what aerobic capacity measures. The option that lists all these interacting mechanisms—lung, heart, blood, vessels, and muscle—best captures why aerobic capacity declines in cancer. The other statements imply improvements or focus on a single system, which doesn’t reflect the multifactorial, often detrimental, impact cancer and its treatments have on aerobic capacity.

Aerobic capacity is limited by how well the body delivers and uses oxygen during exercise, and cancer affects multiple systems that contribute to this. The lungs may not exchange gases efficiently (pulmonary impairment), the heart’s pumping ability can be reduced (cardiac impairment), blood oxygen-carrying capacity can drop due to anemia and other hematologic changes, the vasculature can be damaged or toxic (vascular toxicity), and skeletal muscles can waste away or have metabolic changes that reduce their ability to use oxygen. Taken together, these factors lower maximal oxygen uptake (VO2 max), which is what aerobic capacity measures. The option that lists all these interacting mechanisms—lung, heart, blood, vessels, and muscle—best captures why aerobic capacity declines in cancer. The other statements imply improvements or focus on a single system, which doesn’t reflect the multifactorial, often detrimental, impact cancer and its treatments have on aerobic capacity.